HEALTH

INDIANAPOLIS — Drug maker Eli Lilly has expanded its Spanish-language portal, the company said Friday.

Subsidiary Lilly USA launched an expanded "En Español" section of the Lilly For Better Health website. The section features a 60-page interactive health album that provides tips on healthy eating, physical activity and managing health conditions, as well as health-and-wellness quizzes and risk assessments on weight management, diabetes and other topics.

NORWELL, Mass. — Carex Health Brands recently launched four new products — the Carex Mobilator, the Carex Self Standing Cane Tip, the Carex E-Z Bath & Shower Seat and the Bathroom Safety Rail — across its portfolio of durable medical equipment and life assistance offerings.

GLENVIEW, Ill. — Mead Johnson Nutrition Wednesday evening announced a number of management changes under Mead Johnson president and CEO Steve Golsby.

“Given the growing size and complexity of our global operations, I recognized the need to refine our management structure in order to drive superior performance and operationalize our ambitious strategic plan,” Golsby said.

CHEVY CHASE, Md. — A recent study of obese and nonobese children found that low vitamin D levels are significantly more prevalent in obese children and are associated with risk factors for Type 2 diabetes. This study was accepted for publication in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

BOCA RATON, Fla. — Long-time industry veteran Jonathan Stern, 69, passed last month at his home in Boca Raton, Fla., after a one-year battle with pancreatic cancer. Services were held Nov. 13 at Riverside Memorial Chapel in New York.
 
Stern was credited with building the Keystone Organization into a leading health and beauty sales agency, which merged into Crossmark in 2000. Stern retired two years after the Keystone/Crossmark merger but came out of retirement to serve as an honorary chairman for the Greenwood Group in 2004.
 

ARLINGTON, Va. — The Healthcare Distribution Management Association on Tuesday honored Sen. Pat Roberts, R-Kan., with its Rx Safety and Healthcare Leadership Award. The award recognizes public officials for their leadership and commitment to public policies that support and promote the safe and efficient delivery of medicines.

INDIANAPOLIS — A drug currently under clinical development for Type 2 diabetes produced "meaningful" reductions in blood sugar, according to results of a late-stage clinical study.

Eli Lilly & Co. and Boehringer Ingelheim announced results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, presenting results at the International Diabetes Federation World Diabetes Conference in Dubai.

DUBAI, United Arab Emirates — A combination of two insulins made by Novo Nordisk reduced abnormally low blood sugar in diabetes patients, according to study results presented at a medical conference.